FDA Investigator Grace E Mcnally
Grace E Mcnally has conducted inspections on 54 sites in 8 countries as of 22 Sep 2008. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
54
Last Inspection Date:
22 Sep 2008
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Germany,
India,
United States of America,
China,
Netherlands,
United Kingdom of Great Britain and Northern Ireland,
Canada,
Spain
FDA Investigators that have inspected at least one site in common with Grace E Mcnally:
Ademola O Daramola,
Alan P Kurtzberg,
Alanna L Mussawwir Bias,
Althea A Williams,
Amanda S Zorn,
Andrea A Branche,
Angelica G Aziz,
Anita Narula, PhD,
Ann Marie Montemurro,
Anthony J Lagreca,
Ashleigh P Barkans,
Ashleigh P Wodushek,
Azza Talaat,
Betty Kay Baxter,
Bryan A Galvez,
Bryan J Love,
Bryce A Hammer,
Carla A Norris,
Caroline H Le,
Chani Broner, PhD,
Charisse K Green,
Charles R Cote, RIC,
Christine I Shaw,
Christine W Twohy,
Cody D Rickman,
Cynthia Jim, CSO,
Cynthia T Cain,
Daniel J Grabicki,
Daniel J Lahar,
Daniel J Roberts,
Daniel Pst Laurent,
David J Gomes,
Deborah A Greco,
Debra I Love,
Debra L Curtis,
Dogbeda F Mackenzie,
Dolores Harper,
Dr. Barbara D Paul, PhD,
Dr. Robert C Horan, MD,
Edith M Gonzalez,
Eileen T Dupont,
Eric C Fox,
Eric S Myskowski,
Erik W Burrows,
Erika V Butler,
Esther C Broner, PhD,
Farhana Khan,
Felix Maldonado,
Frank Verni,
Frederic W French, III,
Gary C Pecic, Jr,
George G Calafactor,
George J Flynn,
Gerard T Schneider,
Ginger M Sykes,
Gwyn G Dickinson,
Hanna L Potter,
Haroon Vohra (NMI),
Isabel Y Espinosa,
Jacqueline Mdiaz Albertini,
Jacqueline S Warner,
Jai P Singh,
James L Dunnie, Jr,
James M Odonnell,
James R Montero,
James W Plucinski,
Jamie L Dion,
Janet Pulver,
Jessie E Morris,
Jianming Li,
Joey V Quitania,
Jose A Lopez,
Jose R Hernandez,
Joseph R Strelnik,
Juan A Morales,
Junho Pak,
Justin R Carr,
Kalavati Suvarna, PhD,
Karen G Hirshfield,
Katherine Szestypalow,
Kathleen S Tormey,
Kathryn M Mogen,
Kelly D Moore,
Kenneth H Williams,
Kent C Faul,
Kevin A Gonzalez,
Kevin D Kallander,
Kham Phommachanh,
Khumo A Phake,
Kimberley A Hoefen,
Kimetha A King,
Kristen E Szenderski,
Larisa E Pavlick,
Larry K Austin,
Laura B Kennedy,
Lavender M Huskey,
LCDR Ismael Olvera, IV,
Lewis K Antwi,
Linda M Cheny,
Lori A Carr,
Luis A Dasta,
Lydia I Rosas Marty,
Manuel A Moreno,
Marc A Jackson, Jr,
Marie B Buen Bigornia,
Marie F Morin,
Marijo B Kambere, PhD,
Marion W Nadeau,
Mariza M Jafary,
Marlene G Swider,
Marsha L Mccauley,
Martina E Lagrange,
Matthew J Hansen,
Matthew M Vernon,
Matthew R Dionne,
Meyer J Slobotsky,
Michael A Charles,
Michael E Maselli,
Michael J Kuchta,
Michael R Goga,
Michael S Araneta,
Michele L Obert,
Mihaly S Ligmond,
Minh D Phan,
Muralidhara B Gavini, PhD,
Nancy G Schmidt,
Nancy L Neiger,
Nathan M Jornod,
Nathan R Moon,
Nayan J Patel,
Nicholas R Nance,
Nicholas Z Lu,
Oluwaseyi Ojinni,
Omotunde O Osunsanmi,
Parul M Patel,
Patricia A Brown,
Patricia A Cortez,
Patricia A Maestas,
Paul J Teitell,
Paul Z Balcer,
Paula A Trost,
Peter E Baker,
Philip E Ake,
Prabhu P Raju,
Reba A Gates,
Regina T Brown,
Richard Jay Tucker, RS,
Richard L Rutherford,
Ricki A Chase,
Robert D Tollefsen,
Robert J Doyle,
Rochelle L Cross,
Roger F Zabinski,
Roger L Farmer,
Ronda Rloyd Jones,
Rose Ashley,
Rowena S Nguyen,
Sandra A Boyd,
Santiago Gallardo Johnson,
Scott R Izyk,
Scott T Panagiotis,
Sheila Alaghemand,
Shererk,
Sidney B Priesmeyer,
Stephen D Brown,
Stephen D Eich,
Steve P Yost,
Steve Y Rhieu, PhD,
Steven C Madzo,
Steven O Gauthier,
Susan M Jackson,
Susan W Ting,
Tamil Arasu, PhD,
Tara L Breckenridge,
Tara L Greene,
Thai T Duong,
Theressa B Smith,
Thomas S Savage,
Thomas V Anderson,
Torrance J Slayton,
Unnee Ranjan,
Verlinda A Narcisse,
Vicky L Cruz,
Wanda B Coats,
Wayne W Grundstrom,
Wdouglas Rowe,
William A Warnick,
Yasamin Ameri,
Zachary A Bogorad,
Zachary L Miller,
Zachary L Stamm,
Zhong Li, PhD
Grace E Mcnally's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| March, 2002 | FDA 483 | MedMira Laboratories Inc. - Form 483, 2002-03-27 |
| December, 2001 | FDA 483 | Nelson Laboratories, LLC - Form 483, 2001-12-19 |
| December, 2001 | EIR | Nelson Laboratories, LLC - EIR, 2001-12-19 |
| January, 2000 | FDA 483 | Medical Systems of Denver, Inc. - Form 483, 2000-01-18 |
| October, 2003 | EIR | Cirrus Laboratories - EIR, 2003-11-14 |
| October, 2000 | EIR | IDEMSA - EIR, 2000-10-05 |
| October, 2000 | FDA 483 | IDEMSA - Form 483, 2000-10-05 |
| September, 2008 | FDA 483 | XIAN LIJUN PHARMACEUTICAL CO., LTD. - Form 483, 2008-09-19 |
| October, 2003 | FDA 483 Response | CP Pharmaceuticals Ltd - Form 483R, 2004-01-08 |
| September, 2008 | EIR | XIAN LIJUN PHARMACEUTICAL CO., LTD. - EIR, 2009-04-15 |
| October, 2003 | EIR | CP Pharmaceuticals Ltd - EIR, 2003-12-10 |
| October, 2003 | FDA 483 Response | Cirrus Laboratories - Form 483R, 2003-11-24 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more